Funded Health Care Startups in Palo Alto
Among the 14 Palo Alto health care entries shown, the largest disclosed round is Medable’s $304M Series D on 2021-10-26, which dwarfs the next-largest disc…
Among the 14 Palo Alto health care entries shown, the largest disclosed round is Medable’s $304M Series D on 2021-10-26, which dwarfs the next-largest disclosed amounts ($100M for Avail Medsystems on 2020-10-07, then $52M for Endpoint Health on 2022-06-02, $50M for Health Gorilla on 2022-03-07, and $33M for Atropos Health on 2024-05-23). The disclosed amounts cluster more tightly below $52M, while undisclosed rounds appear at the edges of the time window (MiSalud on 2025-11-09; HealthyLongevity on 2022-11-01; FidoCure on 2022-07-19).
Stage labels are missing or non-specific in multiple rows: 3 of 14 entries are marked “undisclosed” on amount and 5 of 14 use “Series Unknown” or blank stage text (MiSalud, Mon Ami, FidoCure, Vynca, Fable, and Avail Medsystems’s blank stage). Temporally, the rounds span 2020-10-07 through the most recent 2025-11-09, with two noticeable active pockets: late 2023 (three disclosed rounds between 2023-07-12 and 2023-11-15) and early-to-mid 2022 (four rounds between 2022-01-07 and 2022-07-19). All rows are in Palo Alto, California, indicating a single-city geographic concentration in the dataset.
Most recent rounds
14 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Palo Alto health care list, and how unusual is it versus the rest of the disclosed deals?
Medable’s $304M Series D on 2021-10-26 is the clear outlier; the next-largest disclosed amounts are $100M (Avail Medsystems on 2020-10-07), then $52M (Endpoint Health on 2022-06-02) and $50M (Health Gorilla on 2022-03-07), with most other disclosed rounds falling below that range (for example, $33M for Atropos Health on 2024-05-23).
Do the rounds cluster in time, or are they evenly spread across 2020–2025?
They cluster. After the 2020-10-07 start (Avail Medsystems), there are four entries between 2022-01-07 and 2022-07-19 (Vynca, Health Gorilla, Endpoint Health, FidoCure), and another multi-deal burst in late 2023 (Gradia Health on 2023-07-12, Inito on 2023-11-15, and Mon Ami on 2023-11-06).
Which deals use non-specific or missing funding information (amount or stage), and how much of the list does that represent?
Non-specific data is common: 3 of 14 entries are “undisclosed” on amount (MiSalud on 2025-11-09; HealthyLongevity on 2022-11-01; FidoCure on 2022-07-19). For stage, 5 of 14 use “Series Unknown” or blank stage text (MiSalud; Mon Ami; FidoCure; Vynca; Fable; plus Avail Medsystems has a blank stage field).
What stage mix dominates where amounts are disclosed, and how does it compare to earlier rounds?
Among disclosed amounts, multiple rounds land in the $20M–$52M range across different stages: Vynca is $27M (Venture - Series Unknown) on 2022-01-07, Fable is $20M (Venture - Series Unknown) on 2021-11-08, and Endpoint Health is $52M (Series A) on 2022-06-02. Higher-disclosure “late-stage” appears with Medable’s $304M Series D (2021-10-26) and subsequent large rounds like Health Gorilla’s $50M Series C (2022-03-07), while early-stage entries also show up (e.g., Odyssey $1M Pre-Seed on 2025-04-01 and Gradia Health $4M Seed on 2023-07-12).
Are there any near-term entries relative to the most recent date in the table?
The most recent row is MiSalud on 2025-11-09, but only one other 2025 entry appears: Odyssey on 2025-04-01. From that 2025-04-01 point forward, the table shows limited follow-on activity within the same year, with the next closest dates in 2024 (Atropos Health on 2024-05-23 and none between 2024-05-23 and 2025-04-01).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.